<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03187249</url>
  </required_header>
  <id_info>
    <org_study_id>2016YFC1304404B</org_study_id>
    <nct_id>NCT03187249</nct_id>
  </id_info>
  <brief_title>Intervention Strategy in Chronic Obstructive Pulmonary Disease With Anxiety and Depression</brief_title>
  <official_title>Intervention Strategy in Chronic Obstructive Pulmonary Disease With Anxiety and Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Academy of Medical Sciences, Fuwai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Academy of Medical Sciences, Fuwai Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anxiety and depression have negative effect on outcomes of chronic obstructive pulmonary&#xD;
      disease (COPD). Intervention strategy including behavioral-cognitive therapy and pulmonary&#xD;
      rehabilitation are promising in improving life quality, disease symptom and outcomes. But&#xD;
      there's not standard algorithm in China so far. The study aims to compare the effectiveness&#xD;
      of these interventions and develop an intervention algorithm of anxiety and depression in&#xD;
      COPD.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Anticipated">June 15, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital Anxiety and Depression Scale</measure>
    <time_frame>12 weeks</time_frame>
    <description>total score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>moderate and severe COPD exacerbations</measure>
    <time_frame>3 years</time_frame>
    <description>total times</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified British medical research council score</measure>
    <time_frame>3 years</time_frame>
    <description>total score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>COPD assessment test score</measure>
    <time_frame>3 years</time_frame>
    <description>total score</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>COPD</condition>
  <condition>Anxiety</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Cognitive Behavioral Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>receive cognitive-behavioral therapy for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pulmonary Rehabilitation Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>receive pulmonary rehabilitation therapy for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>receive both cognitive-behavioral therapy and pulmonary rehabilitation therapy for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Regular Therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>receive regular therapy for chronic obstructive pulmonary disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy</intervention_name>
    <description>12 weeks cognitive-behavioral lessons, once a week</description>
    <arm_group_label>Cognitive Behavioral Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pulmonary Rehabilitation Therapy</intervention_name>
    <description>12 weeks pulmonary rehabilitation exercise</description>
    <arm_group_label>Pulmonary Rehabilitation Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Combined Therapy</intervention_name>
    <description>cognitive-behavioral lessons and pulmonary rehabilitation exercise for 12 weeks</description>
    <arm_group_label>Combined Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Stable COPD patients with mild or moderate anxiety and depression&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with bronchial asthma or other severe pulmonary diseases or having received&#xD;
             pulmonary surgery in 6 months&#xD;
&#xD;
          -  Patients with tumor history during past 5 years&#xD;
&#xD;
          -  Patients with COPD exacerbations during past 4 weeks&#xD;
&#xD;
          -  Participants in clinical trials&#xD;
&#xD;
          -  Patients in pregnancy or breastfeeding&#xD;
&#xD;
          -  Patients unable to complete questionaire independently&#xD;
&#xD;
          -  Patients older than 80 years old&#xD;
&#xD;
          -  Patients receiving long-term domiciliary oxygen therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jiangna Han, MD</last_name>
    <phone>13520053104</phone>
    <email>13520053104@139.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiangna Han, MD</last_name>
      <phone>13520053104</phone>
      <email>13520053104@139.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <study_first_submitted>June 13, 2017</study_first_submitted>
  <study_first_submitted_qc>June 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2017</study_first_posted>
  <last_update_submitted>June 13, 2017</last_update_submitted>
  <last_update_submitted_qc>June 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Academy of Medical Sciences, Fuwai Hospital</investigator_affiliation>
    <investigator_full_name>Jianguo He</investigator_full_name>
    <investigator_title>Chief of Pulmonary Vascular Disease Center</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

